Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News Quantum-Si secures $50m in registered direct offering to expand single-molecule protein sequencing platform Quantum-Si Incorporated secures $50 million through a registered direct offering of common stock, bolstering its single-molecule proteomics platform. byPallavi MadhirajuJuly 7, 2025